Northwest & Ethical Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.72M | Buy |
15,089
+530
| +4% | +$236K | 0.17% | 156 |
|
|
2025
Q1 | $7.06M | Sell |
14,559
-13,263
| -48% | -$6.43M | 0.19% | 146 |
|
|
2024
Q4 | $11.2M | Buy |
27,822
+1,182
| +4% | +$476K | 0.3% | 106 |
|
|
2024
Q3 | $12.4M | Buy |
26,640
+2,596
| +11% | +$1.21M | 0.33% | 105 |
|
|
2024
Q2 | $11.3M | Hold |
24,044
| – | – | 0.32% | 103 |
|
|
2024
Q1 | $10.1M | Sell |
24,044
-18,810
| -44% | -$7.86M | 0.29% | 114 |
|
|
2023
Q4 | $17.4M | Buy |
42,854
+4,339
| +11% | +$1.77M | 0.54% | 58 |
|
|
2023
Q3 | $13.4M | Buy |
38,515
+16,818
| +78% | +$5.85M | 0.45% | 74 |
|
|
2023
Q2 | $7.64M | Buy |
21,697
+5,803
| +37% | +$2.04M | 0.24% | 129 |
|
|
2023
Q1 | $5.01M | Buy |
15,894
+11,530
| +264% | +$3.63M | 0.17% | 173 |
|
|
2022
Q4 | $1.26M | Sell |
4,364
-8,790
| -67% | -$2.54M | 0.04% | 279 |
|
|
2022
Q3 | $3.81M | Sell |
13,154
-361
| -3% | -$105K | 0.15% | 181 |
|
|
2022
Q2 | $3.81M | Hold |
13,515
| – | – | 0.14% | 178 |
|
|
2022
Q1 | $3.53M | Sell |
13,515
-8,126
| -38% | -$2.12M | 0.11% | 205 |
|
|
2021
Q4 | $4.75M | Buy |
+21,641
| New | +$4.75M | 0.14% | 169 |
|
|
2021
Q2 | – | Sell |
-6,566
| Closed | -$1.41M | – | 434 |
|
|
2021
Q1 | $1.41M | Buy |
6,566
+3,943
| +150% | +$847K | 0.05% | 305 |
|
|
2020
Q4 | $620K | Buy |
+2,623
| New | +$620K | 0.02% | 348 |
|